PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel approach shows promise for cystic fibrosis, say UAB researchers

2010-11-18
(Press-News.org) Birmingham, Ala. – An investigational drug targeting a defective protein that causes cystic fibrosis has been shown to improve lung function in a small study of CF patients, according to findings published Nov. 18, 2010, in the New England Journal of Medicine. The investigational drug, VX-770, appeared to improve function of what is known as CFTR--the faulty protein responsible for CF. It is among the first compounds being developed for CF that specifically targets the root cause of cystic fibrosis.

Patients who took VX-770 for 28 days showed improvements in several key indicators of cystic fibrosis, including lung function, nasal potential difference measurements and sweat chloride levels. Excessive sweat chloride is a key clinical indicator of CF. The sweat test is the traditional diagnostic test for CF.

"Patients with CF have a defective protein in chloride channels in lung cells that, in effect, causes a door to shut too tightly, ultimately leading to severe infections in the lung" said Steven M. Rowe, M.D., M.S.P.H, assistant professor of medicine at the University of Alabama at Birmingham and lead investigator at the UAB site, one of 16 study sites nationwide for this VX-770 trial. "The data suggest that the drug seems to improve the function of the protein, so that the door opens and closes more properly." UAB also served as the central coordinating center for nasal potential difference testing, an important outcome measure in the trial.

VX-770 was developed by Vertex Pharmaceuticals, in conjunction with the Cystic Fibrosis Foundation, using a cutting-edge technology known as high-throughput screening, an advanced technique for drug discovery. UAB's Gregory Fleming James Cystic Fibrosis Research Center was the first site in the nation to clinically administer VX-770 to CF patients in the trial in May 2007.

Investigators studied 39 patients with CF in the trial who had a specific mutation in the gene known to cause CF. The primary objective of the trial was to demonstrate the safety and tolerability of VX-770. All patients in the trial completed use of the study drug, and adverse events were similar to placebo.

"Nearly a decade ago, the CF Foundation recognized the need to develop new therapies that address the underlying cause of CF and not just the symptoms of the disease. We are encouraged by the data from this Phase 2 trial and see the trial as a milestone in our efforts to discover and develop new treatment options for this disease," said Robert J. Beall, Ph.D., President and CEO of the Cystic Fibrosis Foundation.

VX-770 is currently in Phase 3 clinical trials for cystic fibrosis, and, pending data from these studies, Vertex anticipates submitting a new drug application to the FDA in the second half of 2011.

CF is a fatal genetic disease that affects about 30,000 people in the United States and 70,000 worldwide. It is caused by a genetic mutation that causes life-threatening lung infections and premature death. Ten million Americans are symptomless carriers of a defective CF gene.

INFORMATION: Other collaborators on the study are the University of Colorado, Denver and Children's Hospital, Aurora; Johns Hopkins Medical Institutions; University of Minnesota; Hospital for Sick Children and the University of Toronto; University of Iowa; Children's Hospital and Case Western Reserve University School of Medicine, Cleveland; University of North Carolina; Stanford University School of Medicine; University of Pittsburgh; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine; Children's Hospital Boston and Beth Israel Deaconess Medical Center; University of Washington and Seattle Children's Hospital.

About UAB

Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham (UAB) is the state of Alabama's largest employer and an internationally renowned research university and academic health center; its professional schools and specialty patient-care programs are consistently ranked among the nation's top 50. Find more information at www.uab.edu and www.uabmedicine.org.

EDITOR'S NOTE: The University of Alabama at Birmingham (UAB) is a separate, independent institution from the University of Alabama, which is located in Tuscaloosa. Please use University of Alabama at Birmingham on first reference and UAB on second reference.

VIDEO: www.youtube.com/uabnews TEXT: www.uab.edu/news TWEETS: www.twitter.com/uabnews



ELSE PRESS RELEASES FROM THIS DATE:

IQ scores fail to predict academic performance in children with autism

2010-11-18
New data show that many children with autism spectrum disorders have greater academic abilities than previously thought. In a study by researchers at the University of Washington, 90 percent of high-functioning children with autism spectrum disorders showed a discrepancy between their IQ score and their performance on reading, spelling and math tests. "Academic achievement is a potential source of self-worth and source of feeling of mastery that people may not have realized is available to children with autism," said Annette Estes, research assistant professor at the ...

As Arctic temperatures rise, tundra fires increase, researchers find

As Arctic temperatures rise, tundra fires increase, researchers find
2010-11-18
CHAMPAIGN, Ill. — In September, 2007, the Anaktuvuk River Fire burned more than 1,000 square kilometers of tundra on Alaska's North Slope, doubling the area burned in that region since record keeping began in 1950. A new analysis of sediment cores from the burned area revealed that this was the most destructive tundra fire at that site for at least 5,000 years. Models built on 60 years of climate and fire data found that even moderate increases in warm-season temperatures in the region dramatically increase the likelihood of such fires. The study was published this October ...

Hearing loss study reveals role of bone hardness in tissue function

2010-11-18
Scientists are reporting the first direct evidence that a subtle change in the physical properties of a tissue can affect its function. The finding has immediate implications for understanding several rare hearing disorders, they said, and ultimately could offer insight into such conditions as osteoporosis, arthritis, cardiovascular disease and cancer. In their study, the scientists discovered that blocking the function of a particular molecule in the ear bone of mice decreased the hardness of the bone, causing hearing loss. Reactivating the molecule restored the bone's ...

National Zoo and partners first to breed critically endangered tree frog

National Zoo and partners first to breed critically endangered tree frog
2010-11-18
As frogs around the world continue to disappear—many killed by a rapidly spreading disease called chytridiomycosis, which attacks the skin cells of amphibians—one critically endangered species has received an encouraging boost. Although the La Loma tree frog, Hyloscirtus colymba, is notoriously difficult to care for in captivity, the Panama Amphibian Rescue and Conservation Project is the first to successfully breed this species. "We are some of the first researchers to attempt to breed these animals into captivity and we have very little information about how to care ...

Antimatter atoms stored for the first time

Antimatter atoms stored for the first time
2010-11-18
Atoms of antimatter have been trapped and stored for the first time by the ALPHA collaboration, an international team of scientists working at CERN, the European Organization for Nuclear Research near Geneva, Switzerland. Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeley have made key contributions to the ongoing international effort. ALPHA stored atoms of antihydrogen, consisting of a single negatively charged antiproton orbited by a single positively charged anti-electron (positron). While ...

Antimatter atoms produced and trapped at CERN

2010-11-18
Geneva, 17 November 2011. The ALPHA experiment at CERN has taken an important step forward in developing techniques to understand one of the Universe's open questions: is there a difference between matter and antimatter? In a paper published in Nature today, the collaboration shows that it has successfully produced and trapped atoms of antihydrogen. This development opens the path to new ways of making detailed measurements of antihydrogen, which will in turn allow scientists to compare matter and antimatter. Antimatter – or the lack of it – remains one of the biggest ...

Pelletized manure reduces toxic runoff

2010-11-18
Madison WI November 17 2010 – There is considerable amount of uncertainty concerning the environmental impacts that animal hormones have on surface water. Higher concentrations of hormones in waterways have been found to cause physiological and sexual impairment in fish and other aquatic species. However, a study from the University of Delaware that examined estrogen concentrations runoff from agricultural fields fertilized with chicken manure found that it is as much about the application of the manure as it is about the measurement of the types of estrogen. The study ...

College job market to see slight rebound

College job market to see slight rebound
2010-11-18
EAST LANSING, Mich. — The national job market for college graduates should rebound slightly next year as many large corporations end hiring freezes and small, fast-growth companies continue helping reshape the economy, according to Michigan State University's 2010-11 Recruiting Trends report. Overall hiring is expected to increase 3 percent, with bachelor's-level and MBA-level hiring both surging 10 percent, said Phil Gardner, director of MSU's Collegiate Employment Research Institute, which conducted the survey of some 4,600 employers. Geographically, the Great Lakes ...

Nanoscale probe reveals interactions between surfaces and single molecules

2010-11-18
As electronics become smaller and smaller the need to understand nanoscale phenomena becomes greater and greater. Because materials exhibit different properties at the nanoscale than they do at larger scales, new techniques are required to understand and to exploit these new phenomena. A team of researchers led by Paul Weiss, UCLA's Fred Kavli Chair in NanoSystems Sciences, has developed a tool to study nanoscale interactions. Their device is a dual scanning tunneling and microwave-frequency probe that is capable of measuring the interactions between single molecules and ...

Coaching with compassion can 'light up' human thoughts

2010-11-18
CLEVELAND – Coaching happens just about everywhere, and every day, with learning as the goal. Effective coaching can lead to smoothly functioning organizations, better productivity and potentially more profit. In classrooms, better student performance can occur. Doctors or nurses can connect more with patients. So, doing coaching right would seem to be a natural goal, and it has been a major topic of research at Case Western Reserve University's Weatherhead School of Management since 1990. For all the energy and money spent on coaching, there is little understanding ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] Novel approach shows promise for cystic fibrosis, say UAB researchers